Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Morten Bækken"'
Autor:
Ingjerd W. Manner, Bård Waldum-Grevbo, Birgit Nomeland Witczak, Morten Bækken, Olav Øktedalen, Ingrid Os, Thomas Schwartz, Ivar Sjaastad
Publikováno v:
Blood Pressure, Vol 26, Iss 6, Pp 332-340 (2017)
Purpose: Non-dipping nocturnal blood pressure (BP) pattern has been reported prevalent among HIV-infected patients and is associated with adverse cardiovascular outcomes. The aims of this observational study were to identify predictors of nocturnal B
Externí odkaz:
https://doaj.org/article/1307154fbd294ef29500fffb85a378f4
Autor:
Birgit Nomeland Witczak, Thomas Schwartz, Ingjerd W. Manner, Ivar Sjaastad, Bård Waldum-Grevbo, Ingrid Os, Olav Øktedalen, Morten Baekken
Publikováno v:
Blood Pressure. 26:332-340
Purpose: Non-dipping nocturnal blood pressure (BP) pattern has been reported prevalent among HIV-infected patients and is associated with adverse cardiovascular outcomes. The aims of this observational study were to identify predictors of nocturnal B
Autor:
Marius Trøseid, Susanne Dam Nielsen, Dag Kvale, Olav Oektedalen, Ingrid Os, Morten Baekken, Piotr Nowak, Ingjerd W. Manner
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 65:e158-e161
Autor:
Maria Pedersen, Olav Oektedalen, Piotr Nowak, Dag Kvale, Susanne Dam Nielsen, Ingjerd W. Manner, Ingrid Os, Marius Trøseid, Morten Baekken
Publikováno v:
HIV Medicine. 14:354-361
Objectives The aim of the study was to test the hypothesis that microbial translocation, quantified by levels of lipopolysaccharide (LPS) and subsequent monocyte activation [soluble (sCD14)], is associated with hypertension in HIV-infected individual
Publikováno v:
The Journal of Clinical Hypertension. 15:101-106
Hypertension is associated with cardiovascular disease in the human immunodeficiency virus (HIV)–infected population. The authors aimed to test the hypothesis whether advanced immunosuppression with low nadir CD4 lymphocyte cell count is a predicto
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Publikováno v:
Blood Pressure. 21:311-319
Hypertension is a significant contributor to cardiovascular disease in HIV-infected individuals. The purposes of this study were to assess the development of new-onset hypertension and the use of antihypertensive treatment and blood pressure (BP) con
Publikováno v:
Blood Pressure. 19:188-195
There is a scarcity of data on ambulatory blood pressure (ABP) in HIV-infected individuals. The aim of the study was to identify possible predictors of ABP in HIV-infected individuals.From a cohort of 542 HIV-infected patients, ABP monitoring was und
Publikováno v:
Journal of Hypertension. 26:2126-2133
Hypertension is a major risk factor for cardiovascular diseases and mortality. The introduction of combination antiretroviral therapy for HIV-infected patients has changed their prognosis substantially, but there is an additional cost from the increa
Publikováno v:
J Clin Hypertens (Greenwich)
Hypertension is associated with cardiovascular disease in the human immunodeficiency virus (HIV)–infected population. The authors aimed to test the hypothesis whether advanced immunosuppression with low nadir CD4 lymphocyte cell count is a predicto
Publikováno v:
Nephrology Dialysis Transplantation
Background. The survival of human immunodeficiency virus (HIV)-infected patients has increased significantly since the introduction of combination antiretroviral therapy, leading to the development of important long-term complications including cardi